Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium

Organomegaly in Mali before and after praziquantel treatment. A possible association with Schistosoma haematobium

Continuous exposure to schistosome-infested water results in acute and chronic morbidity in all ages. We analysed occurence of organomegaly via ultrasonography and investigated a possible additive effect of dual-dose drug administration in 401 Schistosoma haematobium infected individuals from a high...

Full description

Bibliographic Details
Main Authors:	Chalotte Willemann Stecher, Henry Madsen, Shona Wilson, Moussa Sacko, Christian Wejse, Adama D. Keita, Aly Landouré, Mamadou S. Traoré, Per Kallestrup, Eskild Petersen, Birgitte Vennervald
Format:	Article
Language:	English
Published:	Elsevier 2017-11-01
Series:	Heliyon
Subjects:	Infectious disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844017300968

Similar Items

Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children.
by: Mahamadou S Sissoko, et al.
Published: (2009-10-01)

Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial.
by: Jennifer Keiser, et al.
Published: (2014-07-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: G.C. Coles, et al.
Published: (2001-12-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya
by: Charles H. King, et al.
Published: (2000-12-01)

State-space forecasting of Schistosoma haematobium time-series in Niono, Mali.
by: Daniel C Medina, et al.
Published: (2008-01-01)

Therapeutic failure of praziquantel in the treatment of Schistosoma haematobium infection in Brazilians returning from Africa
by: Iran Mendonça da Silva, et al.
Published: (2005-07-01)

Efficacy and safety of praziquantel against Schistosoma haematobium in the Ikata-Likoko area of southwest Cameroon
by: Calvin Bisong Ebai, et al.
Published: (2017-12-01)

In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium
by: Jana Kovač, et al.
Published: (2017-08-01)

Efficacy and safety of praziquantel in preschool-aged children in an area co-endemic for Schistosoma mansoni and S. haematobium.
by: Jean T Coulibaly, et al.
Published: (2012-01-01)

<it>Schistosoma haematobium</it> infections among schoolchildren in central Sudan one year after treatment with praziquantel
by: Ahmed Abedaziz M, et al.
Published: (2012-06-01)

Schistosoma haematobium
by: Cristina Corsini Campioli, et al.
Published: (2023-01-01)

Downregulation of MIP-1α/CCL3 with praziquantel treatment in <it>Schistosoma haematobium </it>and HIV-1 co-infected individuals in a rural community in Zimbabwe
by: Ullum H, et al.
Published: (2009-10-01)

Rapidly boosted Plasma IL-5 induced by treatment of human Schistosomiasis haematobium is dependent on antigen dose, IgE and eosinophils.
by: Shona Wilson, et al.
Published: (2013-01-01)

Schistosoma haematobium treatment in 1-5 year old children: safety and efficacy of the antihelminthic drug praziquantel.
by: Francisca Mutapi, et al.
Published: (2011-05-01)

Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
by: Bridget W Kimani, et al.
Published: (2018-10-01)

Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2019-12-01)

Use of Bayesian geostatistical prediction to estimate local variations in Schistosoma haematobium infection in western Africa
by: Archie CA Clements, et al.
Published: (2009-12-01)

Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial.
by: Beatrice Barda, et al.
Published: (2016-09-01)

Co-infection with Schistosoma haematobium and soil-transmitted helminths in rural South Africa
by: Mari Molvik, et al.
Published: (2017-03-01)

Evidence Against Rapid Emergence of Praziquantel Resistance in Schistosoma haematobium, Kenya--Reply to Drs. Coles, Liang, and Doenhoff
by: C. H. King, et al.
Published: (2001-12-01)

Dynamics of <it>Schistosoma haematobium </it>egg output and associated infection parameters following treatment with praziquantel in school-aged children
by: Stete Katarina, et al.
Published: (2012-12-01)

Correction to: Schistosoma haematobium infection morbidity, praziquantel effectiveness and reinfection rate among children and young adults in Gabon
by: Jean Claude Dejon-Agobé, et al.
Published: (2021-06-01)

Significantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatment.
by: Aly Landouré, et al.
Published: (2012-01-01)

Infection intensity-dependent accuracy of reagent strip for the diagnosis of Schistosoma haematobium and estimation of treatment prevalence thresholds.
by: Carla M Grolimund, et al.
Published: (2022-04-01)

Three monthly doses of 60 mg/kg praziquantel for Schistosoma haematobium infection is a safe and effective treatment regimen
by: Samuel Nkansah Darko, et al.
Published: (2020-05-01)

High Efficacy of Praziquantel in Schistosoma haematobium-Infected Children in Taraba State, Northeast Nigeria: A follow-up study
by: Robert S. Houmsou, et al.
Published: (2018-12-01)

Protective human IgE responses are promoted by comparable life-cycle dependent Tegument Allergen-Like expression in Schistosoma haematobium and Schistosoma mansoni infection.
by: Rebecca C Oettle, et al.
Published: (2023-05-01)

Protective human IgE responses are promoted by comparable life-cycle dependent Tegument Allergen-Like expression in Schistosoma haematobium and Schistosoma mansoni infection
by: Rebecca C. Oettle, et al.
Published: (2023-05-01)

The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection
by: T Mduluza, et al.
Published: (2001-09-01)

The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment
by: Koukounari Artemis, et al.
Published: (2010-07-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

CRISPR-assisted test for Schistosoma haematobium
by: Dounia Cherkaoui, et al.
Published: (2023-03-01)

Colon polyps in Schistosoma haematobium schistosomiasis
by: Celso Alberto Chassot, et al.
Published: (1998-01-01)

Schistosoma haematobium Infection and Buruli Ulcer
by: Janet T. Scott, et al.
Published: (2004-03-01)

The usefulness of indirect diagnostic tests for Schistosoma haematobium infection after repeated rounds of mass treatment with praziquantel in Mpwapwa and Chakechake districts in Tanzania
by: Billy Ngasala, et al.
Published: (2020-01-01)

Population genetic structure of Schistosoma haematobium and Schistosoma haematobium × Schistosoma bovis hybrids among school-aged children in Côte d’Ivoire
by: Angora Etienne K., et al.
Published: (2022-01-01)

Co-infection of long-term carriers of Plasmodium falciparum with Schistosoma haematobium enhances protection from febrile malaria: a prospective cohort study in Mali.
by: Safiatou Doumbo, et al.
Published: (2014-09-01)

Praziquantel-encapsulated niosomes against Schistosoma mansoni with reduced sensitivity to praziquantel
by: Eglal I. Amer, et al.
Published: (2022-03-01)

Genetic manipulation of Schistosoma haematobium, the neglected schistosome.
by: Gabriel Rinaldi, et al.
Published: (2011-10-01)

The small RNA complement of adult Schistosoma haematobium.
by: Andreas J Stroehlein, et al.
Published: (2018-05-01)